샘플 요청 목록

 카트 문의
시장보고서
상품코드
1792833

세계의 방사선 종양학 시장

Radiation Oncology
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 488 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

방사선 종양학 세계 시장은 2030년까지 102억 달러에 달할 전망

2024년에 79억 달러로 추정되는 방사선 종양학 세계 시장은 분석 기간인 2024-2030년에 CAGR 4.3%로 성장하여 2030년에는 102억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 외부 빔 방사선 치료는 CAGR 3.3%를 기록하며 분석 기간 종료시에는 36억 달러에 달할 것으로 예측됩니다. 근접 방사선 치료 분야의 성장률은 분석 기간 동안 CAGR 5.5%로 추정됩니다.

미국 시장은 22억 달러, 중국은 CAGR 7.6%로 성장할 것으로 예측

미국의 방사선 종양학 시장은 2024년에 22억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 21억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 7.6%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.8%와 3.3%로 예측됩니다. 유럽에서는 독일이 CAGR 2.5%로 성장할 것으로 예측됩니다.

세계의 방사선 종양학 시장 - 주요 동향과 촉진요인 정리

방사선 종양학은 암 치료 수요에 따라 어떻게 진화하고 있는가?

방사선 종양학은 암의 다학제적 치료의 초석이 되고 있으며, 악성조직을 표적으로 하는 효과와 정확도를 높이는 기술 혁신이 계속되고 있습니다. 이 분야는 기존의 방사선 치료에서 강도변조방사선치료(IMRT), 정위방사선수술(SRS), 영상유도방사선치료(IGRT), 양성자선치료 등 고도의 첨단 기술로 크게 변화하고 있습니다. 이러한 치료법은 주변의 건강한 조직을 보존하고, 부작용을 줄이며, 환자의 예후를 개선하는 정확한 선량 조사가 가능합니다. 전 세계 암 발병률의 증가와 고령화로 인해 의료 시스템은 방사선 종양학 인프라와 역량을 확대해야 할 필요성이 대두되고 있습니다.

종양의 유전학적 정보와 방사선학적 데이터에 따라 치료를 조정하는 맞춤 종양학의 도입은 치료 계획을 더욱 재정의하고 있습니다. 인공지능과 기계학습 알고리즘을 방사선 종양학 소프트웨어에 통합하여 환자의 반응과 해부학적 변화에 따라 실시간으로 치료를 조정하는 적응형 방사선 치료를 촉진합니다. 또한, 방사선 생물학 및 저분할 프로토콜의 발전으로 동등하거나 개선된 효능으로 더 짧은 치료 기간이 가능해져 처리량과 환자 편의성이 모두 향상되고 있습니다. 이러한 발전을 통해 방사선 종양학센터는 전 세계적으로 임상적, 운영적 변화를 추진하고 있습니다.

현대 방사선 종양학 진료를 형성하는 기술과 양상은 무엇인가?

리니악(정세), 양성자치료기, 근접방사선치료 장비, 로봇 방사선 수술 플랫폼이 각광을 받고 있습니다. 리니악 시스템은 현재 멀티 리프 콜리메이터(MLC), 체적 변조 아크 치료(VMAT), 온보드 이미징을 통합하여 적은 치료 횟수로 정확한 종양 타겟팅이 가능합니다. 양성자선 치료는 에너지의 대부분을 브래그 피크에 집중시켜 부수적인 손상을 최소화하고 장기적인 독성을 줄일 수 있어 소아암이나 복잡한 종양의 경우 빠르게 도입이 진행되고 있습니다.

또한, 호흡 게이팅 및 실시간 종양 추적과 같은 운동 관리 기술은 특히 폐암과 소화기암에서 치료 중 장기의 움직임에 대처하기 위해 도입되고 있습니다. 자궁경부암, 전립선암, 유방암 등에서는 선량의 국소성이 높고 치료 기간이 짧아 근접방사선치료에 대한 관심이 다시 높아지고 있습니다. MRI 및 PET 영상을 치료 계획 시스템에 통합함으로써 종양 묘사와 적응형 치료 계획을 강화할 수 있습니다. 또한, 표적 방사성 핵종 치료의 새로운 방사성의약품은 전이성 암, 특히 전립선암과 신경내분비종양에 대한 치료 옵션을 넓혀가고 있습니다.

병원과 암센터는 방사선 종양학 혁명에 어떻게 대응하고 있는가?

방사선 종양학과는 새로운 기술, 워크플로우 자동화, 다직종 통합에 대응하기 위해 대대적인 업그레이드를 진행하고 있습니다. 병원은 하이브리드 수술실, 첨단 치료 계획 소프트웨어, 종양 정보 시스템(OIS)에 투자하여 환자 데이터 관리 및 치료 결과 추적을 간소화했습니다. 또한, 방사선 종양학자, 의학물리학자, 선량측정학자, IT 전문가들 간의 협업은 치료 계획과 치료 제공을 최적화하기 위해 기능 간 팀으로 공식화되고 있습니다. 학술 의료 센터는 AI 가이드 적응 계획 도구와 클라우드 기반 윤곽 형성 플랫폼을 도입하여 계획 시간을 단축하고 정확도를 높이는 데 앞장서고 있습니다.

교육 및 인재 개발 또한 적응에 필수적인 요소입니다. 현대 방사선 치료는 복잡하기 때문에 영상 해석, 기계 보정, 네트워크화된 종양학 시스템의 사이버 보안 등의 분야에서 지속적으로 기술을 향상시켜야 합니다. 또한, 병원은 심리사회적 지원, 증상 추적, 원격 상담을 방사선 종양학 치료 경로에 통합하는 환자 중심 모델을 채택하고 있습니다. 세계 종양학 네트워크와 원격 방사선 플랫폼은 첨단 방사선 치료 서비스를 소외된 지역으로 확대하여 암 치료 접근성 격차를 줄이는 데 기여하고 있습니다. 방사선 종양학이 시술 전문에서 완전히 통합된 데이터 기반 치료 모델로 진화하기 위해서는 이러한 운영 및 임상 업그레이드가 핵심입니다.

방사선 종양학 시장의 주요 성장 촉진요인은 무엇인가?

방사선 종양학 시장의 성장은 전 세계 암 발병률 증가, 방사선 치료 기술의 발전, 종양학 인프라에 대한 의료 투자 증가 등 여러 요인에 의해 이루어지고 있습니다. 복잡하고 치료 저항성이 있는 암의 증가로 양성자 치료나 정위적 방사선 치료와 같은 정밀치료에 대한 수요가 증가하고 있습니다. 동시에 AI, 영상처리, 방사선 치료의 기술 융합을 통해 개인화된 치료 계획과 치료 결과 모니터링을 촉진하여 임상 효과와 업무 효율을 향상시키고 있습니다.

정부 자금과 민관 파트너십은 선진국과 신흥 지역 모두에서 방사선 치료 인프라 구축을 가속화하고 있습니다. 또한, 첨단 방사선 치료에 대한 보험 적용 범위가 확대되고 암 조기 발견에 대한 인식이 높아지면서 치료의 보급을 촉진하고 있습니다. 면역치료와 방사선 치료의 새로운 조합을 모색하는 임상시험이 진행 중이며, 향후 몇 년 안에 새로운 치료의 지평을 열 수 있을 것으로 기대됩니다. 이러한 요인들이 복합적으로 작용하여 방사선 종양학은 현대 암 치료의 초석일 뿐만 아니라 끊임없는 기술 혁신과 임상혁신이 진행되는 분야로 자리매김하고 있으며, 전 세계적으로 큰 성장이 기대되는 분야입니다.

부문

치료 유형(외부 빔 방사선 치료, 근접 방사선 치료, 전신 방사선 치료, 정위 방사선 수술), 기술(선형 가속기 기술, 방사성동위원소 기술, 입자선 치료 기술, 토모테라피 기술), 용도(유방암 용도, 전립선암 용도, 폐암 용도, 뇌종양 용도, 두경부암 용도), 최종 용도(병원 최종 용도, 외래 클리닉 최종 용도, 암 연구 기관 최종 용도, 외래 수술 센터 최종 용도)

조사 대상 기업 사례

  • Accuray Incorporated
  • Bionix Radiation Therapy, LLC
  • Brainlab AG
  • Canon Medical Systems Corporation
  • Curium
  • Eckert & Ziegler BEBIG
  • Elekta AB
  • GE Healthcare
  • Hitachi Ltd.
  • IBA(Ion Beam Applications SA)
  • Isoray Inc.
  • Mevion Medical Systems Inc.
  • Nanobiotix
  • Nordion Inc.
  • Optivus Proton Therapy Inc.
  • Panacea Medical Technologies Pvt. Ltd.
  • RefleXion Medical
  • RaySearch Laboratories AB
  • Siemens Healthineers AG
  • Sirtex Medical Limited
  • Varian Medical Systems(Siemens)
  • ViewRay Technologies, Inc.

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계 고유의 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가가 선별한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.25

Global Radiation Oncology Market to Reach US$10.2 Billion by 2030

The global market for Radiation Oncology estimated at US$7.9 Billion in the year 2024, is expected to reach US$10.2 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. External Beam Radiation Therapy, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Brachytherapy segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 7.6% CAGR

The Radiation Oncology market in the U.S. is estimated at US$2.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 7.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Radiation Oncology Market - Key Trends & Drivers Summarized

How Is Radiation Oncology Evolving in Response to Cancer Care Demands?

Radiation oncology continues to be a cornerstone in the multidisciplinary management of cancer, with ongoing innovations enhancing both efficacy and precision in targeting malignant tissues. The field has shifted significantly from conventional radiotherapy to highly advanced techniques such as intensity-modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS), image-guided radiation therapy (IGRT), and proton beam therapy. These modalities allow for accurate dose delivery that spares surrounding healthy tissue, reduces side effects, and improves patient outcomes. Growing cancer incidence worldwide, coupled with an aging population, is pushing healthcare systems to expand radiation oncology infrastructure and capabilities.

The adoption of personalized oncology, where treatment is tailored based on tumor genetics and radiomic data, is further redefining treatment planning. Integration of artificial intelligence and machine learning algorithms into radiation oncology software is facilitating adaptive radiotherapy, which adjusts treatment in real time based on patient response and anatomical changes. Additionally, advancements in radiobiology and hypofractionation protocols are enabling shorter treatment durations with equal or improved efficacy, enhancing both throughput and patient convenience. These developments are driving clinical and operational transformation in radiation oncology centers globally.

Which Technologies and Modalities Are Shaping Modern Radiation Oncology Practice?

Cutting-edge technologies are transforming the landscape of radiation oncology, with linear accelerators (LINACs), proton therapy units, brachytherapy equipment, and robotic radiosurgery platforms gaining prominence. LINAC systems now incorporate multi-leaf collimators (MLCs), volumetric modulated arc therapy (VMAT), and onboard imaging to deliver precise tumor targeting in fewer sessions. Proton therapy, which deposits most of its energy at the Bragg peak, is witnessing rapid adoption in pediatric oncology and complex tumor cases due to its minimal collateral damage and reduced long-term toxicity.

Furthermore, motion management techniques such as respiratory gating and real-time tumor tracking are being incorporated to address organ movement during therapy, particularly in lung and gastrointestinal cancers. Brachytherapy is gaining renewed interest for cervical, prostate, and breast cancers, thanks to its high dose localization and shortened treatment duration. Integration of MRI and PET imaging into planning systems enhances tumor delineation and adaptive treatment planning. Additionally, emerging radiopharmaceuticals in targeted radionuclide therapy are expanding treatment options for metastatic cancers, particularly in prostate and neuroendocrine tumors.

How Are Hospitals and Cancer Centers Adapting to the Radiation Oncology Revolution?

Radiation oncology departments are undergoing significant upgrades to accommodate new technologies, workflow automation, and multidisciplinary integration. Hospitals are investing in hybrid operating suites, advanced treatment planning software, and oncology information systems (OIS) to streamline patient data management and outcome tracking. Additionally, collaborations between radiation oncologists, medical physicists, dosimetrists, and IT professionals are being formalized into cross-functional teams to optimize treatment planning and delivery. Academic medical centers are leading the charge in deploying AI-guided adaptive planning tools and cloud-based contouring platforms that enhance precision while reducing planning time.

Training and workforce development are also critical components of adaptation. The complexity of modern radiotherapy requires constant upskilling in areas such as image interpretation, machine calibration, and cybersecurity for networked oncology systems. Moreover, hospitals are adopting patient-centered models that integrate psychosocial support, symptom tracking, and remote consultations into radiation oncology care pathways. Global oncology networks and tele-radiation platforms are helping extend advanced radiotherapy services to underserved regions, reducing disparities in cancer treatment access. These operational and clinical upgrades are central to radiation oncology’s evolution from a procedural specialty into a fully integrated, data-driven care model.

What Are the Key Growth Drivers of the Radiation Oncology Market?

The growth in the radiation oncology market is driven by several factors, including the global rise in cancer prevalence, advancements in radiotherapy technologies, and increasing healthcare investments in oncology infrastructure. Rising incidence of complex and treatment-resistant cancers is propelling demand for precision-focused modalities like proton therapy and stereotactic radiotherapy. At the same time, technological convergence between AI, imaging, and radiotherapy is facilitating personalized treatment planning and outcome monitoring, which enhances clinical effectiveness and operational efficiency.

Government funding and public-private partnerships are accelerating the deployment of radiotherapy infrastructure in both developed and emerging regions. Additionally, expanding insurance coverage for advanced radiotherapy procedures and increasing awareness about early cancer detection are supporting treatment uptake. Ongoing clinical trials exploring novel combinations of immunotherapy with radiation are expected to open new therapeutic frontiers in the years ahead. Together, these drivers are positioning radiation oncology not only as a cornerstone of modern cancer therapy but also as a field undergoing continuous technological and clinical innovation, with strong growth prospects globally.

SCOPE OF STUDY:

The report analyzes the Radiation Oncology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy, Stereotactic Radiosurgery); Technology (Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology, Tomotherapy Technology); Application (Breast Cancer Application, Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application); End-Use (Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use, Ambulatory Surgery Centers End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Accuray Incorporated
  • Bionix Radiation Therapy, LLC
  • Brainlab AG
  • Canon Medical Systems Corporation
  • Curium
  • Eckert & Ziegler BEBIG
  • Elekta AB
  • GE Healthcare
  • Hitachi Ltd.
  • IBA (Ion Beam Applications SA)
  • Isoray Inc.
  • Mevion Medical Systems Inc.
  • Nanobiotix
  • Nordion Inc.
  • Optivus Proton Therapy Inc.
  • Panacea Medical Technologies Pvt. Ltd.
  • RefleXion Medical
  • RaySearch Laboratories AB
  • Siemens Healthineers AG
  • Sirtex Medical Limited
  • Varian Medical Systems (Siemens)
  • ViewRay Technologies, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Radiation Oncology - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Cancer Incidence Worldwide Throws the Spotlight on Advanced Radiotherapy Modalities
    • Technological Advancements in Image-Guided Radiation Therapy Strengthen Precision Treatment Capabilities
    • Expansion of Linear Accelerator Installations in Emerging Markets Drives Equipment Uptake
    • Integration of Artificial Intelligence in Treatment Planning Accelerates Adoption of Adaptive Therapy Solutions
    • Rising Utilization of Stereotactic Radiosurgery Expands Clinical Applications in Brain and Spine Tumors
    • Growth in Proton and Heavy Ion Therapy Centers Drives Demand for High-End Oncology Infrastructure
    • Collaborations Between Research Institutions and Hospitals Fuel Personalized Oncology Approaches
    • Favorable Reimbursement Policies for Radiation Oncology Procedures Sustain Market Accessibility
    • Growing Adoption of Hypofractionated Radiotherapy Enhances Patient Convenience and Throughput
    • Emergence of Real-Time Tumor Tracking and Motion Management Improves Clinical Outcomes
    • Rising Investments in Hybrid Radiotherapy Systems Strengthen Business Case for Multi-Modality Platforms
    • Expansion of Cancer Care Networks and Outreach Programs Boosts Regional Equipment Penetration
    • Increased Focus on Pediatric Radiation Safety Drives Innovation in Dose Optimization Tools
    • Partnerships With Academic Medical Centers Accelerate Development of Evidence-Based Protocols
    • Government Grants for Cancer Treatment Infrastructure Upgrade Promote Public Hospital Modernization
    • Shift Toward Outpatient Radiotherapy Centers Enhances Equipment Turnaround and Affordability
    • Development of Cloud-Based Treatment Planning Systems Improves Workflow and Collaboration
    • Integration of Immunotherapy and Radiotherapy Approaches Strengthens Clinical Trial Pipelines
    • Surge in Awareness Campaigns on Early Cancer Detection Supports Radiation Oncology Growth
    • AI-Enabled Radiomics and Predictive Modeling Drive Precision Medicine in Radiation Treatment
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Radiation Oncology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Radiation Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Radiation Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Radiation Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for External Beam Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for External Beam Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for External Beam Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Brachytherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Brachytherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Brachytherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Systemic Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Systemic Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Systemic Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Stereotactic Radiosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Stereotactic Radiosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Stereotactic Radiosurgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Prostate Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Prostate Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Prostate Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Lung Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Lung Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Lung Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Brain Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Brain Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Brain Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Head & Neck Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Head & Neck Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Head & Neck Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Breast Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Breast Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Breast Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Outpatient Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Outpatient Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Outpatient Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Cancer Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Cancer Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Cancer Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Linear Accelerators Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Linear Accelerators Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: World 16-Year Perspective for Linear Accelerators Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Radioisotopes Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Radioisotopes Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: World 16-Year Perspective for Radioisotopes Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Particle Therapy Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Particle Therapy Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: World 16-Year Perspective for Particle Therapy Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Tomotherapy Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Tomotherapy Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: World 16-Year Perspective for Tomotherapy Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 56: USA Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: USA 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: USA 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 62: USA Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: USA 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 65: USA Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: USA 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Canada 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Canada 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Canada 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Canada 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • JAPAN
    • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Japan 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Japan 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Japan 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 89: Japan Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Japan Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Japan 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • CHINA
    • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 92: China Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: China 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: China 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 98: China Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: China Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: China 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 101: China Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: China Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: China 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • EUROPE
    • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Radiation Oncology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Radiation Oncology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Europe 16-Year Perspective for Radiation Oncology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Europe 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Europe 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 113: Europe Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Europe Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Europe 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Europe 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • FRANCE
    • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 119: France Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: France Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: France 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 122: France Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: France Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: France 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 125: France Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: France Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: France 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 128: France Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: France Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: France 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • GERMANY
    • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 131: Germany Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Germany Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Germany 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 134: Germany Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Germany Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Germany 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 137: Germany Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Germany Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Germany 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 140: Germany Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Germany Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Germany 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 143: Italy Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Italy Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Italy 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 146: Italy Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Italy Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Italy 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 149: Italy Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Italy Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Italy 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 152: Italy Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Italy Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Italy 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 155: UK Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: UK Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: UK 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 158: UK Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: UK Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: UK 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 161: UK Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: UK Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: UK 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 164: UK Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: UK Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: UK 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 167: Spain Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Spain Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Spain 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 170: Spain Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Spain Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Spain 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 173: Spain Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Spain Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Spain 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 176: Spain Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Spain Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Spain 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 179: Russia Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Russia Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Russia 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 182: Russia Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Russia Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Russia 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 185: Russia Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Russia Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Russia 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 188: Russia Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Russia Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Russia 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Europe Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Europe 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Europe Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Europe 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Europe Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Europe 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Europe Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Europe 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 204: Asia-Pacific Historic Review for Radiation Oncology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Asia-Pacific 16-Year Perspective for Radiation Oncology by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Asia-Pacific Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Asia-Pacific 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Asia-Pacific Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Asia-Pacific 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Asia-Pacific Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Asia-Pacific 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Asia-Pacific Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Asia-Pacific 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 218: Australia Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Australia Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Australia 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 221: Australia Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Australia Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Australia 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 224: Australia Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Australia Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: Australia 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 227: Australia Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Australia Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 229: Australia 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • INDIA
    • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 230: India Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: India Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 232: India 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 233: India Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: India Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 235: India 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 236: India Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: India Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 238: India 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 239: India Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: India Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 241: India 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 242: South Korea Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: South Korea Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 244: South Korea 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 245: South Korea Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: South Korea Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 247: South Korea 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 248: South Korea Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: South Korea Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 250: South Korea 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 251: South Korea Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: South Korea Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 253: South Korea 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Rest of Asia-Pacific Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 256: Rest of Asia-Pacific 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Rest of Asia-Pacific Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 259: Rest of Asia-Pacific 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Rest of Asia-Pacific Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 262: Rest of Asia-Pacific 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Rest of Asia-Pacific Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 265: Rest of Asia-Pacific 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 266: Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 267: Latin America Historic Review for Radiation Oncology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 268: Latin America 16-Year Perspective for Radiation Oncology by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 269: Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Latin America Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 271: Latin America 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 272: Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Latin America Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 274: Latin America 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 275: Latin America Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Latin America Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 277: Latin America 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 278: Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Latin America Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 280: Latin America 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 281: Argentina Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Argentina Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 283: Argentina 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 284: Argentina Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Argentina Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 286: Argentina 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 287: Argentina Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Argentina Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 289: Argentina 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 290: Argentina Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Argentina Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 292: Argentina 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 293: Brazil Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Brazil Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 295: Brazil 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 296: Brazil Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Brazil Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 298: Brazil 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 299: Brazil Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Brazil Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 301: Brazil 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 302: Brazil Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Brazil Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 304: Brazil 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 305: Mexico Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Mexico Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 307: Mexico 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 308: Mexico Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Mexico Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 310: Mexico 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 311: Mexico Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Mexico Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 313: Mexico 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 314: Mexico Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Mexico Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 316: Mexico 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Rest of Latin America Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 319: Rest of Latin America 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Rest of Latin America Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 322: Rest of Latin America 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Rest of Latin America Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 325: Rest of Latin America 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Rest of Latin America Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 328: Rest of Latin America 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 329: Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 330: Middle East Historic Review for Radiation Oncology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 331: Middle East 16-Year Perspective for Radiation Oncology by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 332: Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Middle East Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 334: Middle East 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 335: Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Middle East Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 337: Middle East 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 338: Middle East Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Middle East Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 340: Middle East 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 341: Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Middle East Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 343: Middle East 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 344: Iran Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Iran Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 346: Iran 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 347: Iran Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Iran Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 349: Iran 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 350: Iran Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Iran Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 352: Iran 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 353: Iran Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Iran Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 355: Iran 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 356: Israel Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Israel Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 358: Israel 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 359: Israel Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Israel Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 361: Israel 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 362: Israel Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Israel Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 364: Israel 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 365: Israel Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Israel Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 367: Israel 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Saudi Arabia Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 370: Saudi Arabia 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Saudi Arabia Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 373: Saudi Arabia 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Saudi Arabia Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 376: Saudi Arabia 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Saudi Arabia Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 379: Saudi Arabia 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 380: UAE Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: UAE Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 382: UAE 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 383: UAE Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: UAE Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 385: UAE 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 386: UAE Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: UAE Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 388: UAE 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 389: UAE Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: UAE Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 391: UAE 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Rest of Middle East Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 394: Rest of Middle East 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Rest of Middle East Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 397: Rest of Middle East 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Rest of Middle East Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 400: Rest of Middle East 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Rest of Middle East Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 403: Rest of Middle East 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030
  • AFRICA
    • Radiation Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 404: Africa Recent Past, Current & Future Analysis for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Africa Historic Review for Radiation Oncology by Treatment Type - External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 406: Africa 16-Year Perspective for Radiation Oncology by Treatment Type - Percentage Breakdown of Value Sales for External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy and Stereotactic Radiosurgery for the Years 2014, 2025 & 2030
    • TABLE 407: Africa Recent Past, Current & Future Analysis for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Africa Historic Review for Radiation Oncology by Application - Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 409: Africa 16-Year Perspective for Radiation Oncology by Application - Percentage Breakdown of Value Sales for Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application and Breast Cancer Application for the Years 2014, 2025 & 2030
    • TABLE 410: Africa Recent Past, Current & Future Analysis for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 411: Africa Historic Review for Radiation Oncology by End-Use - Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 412: Africa 16-Year Perspective for Radiation Oncology by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
    • TABLE 413: Africa Recent Past, Current & Future Analysis for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 414: Africa Historic Review for Radiation Oncology by Technology - Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 415: Africa 16-Year Perspective for Radiation Oncology by Technology - Percentage Breakdown of Value Sales for Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology and Tomotherapy Technology for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제